Breaking News Instant updates and real-time market news.

VRX

Valeant

$13.97

-0.415 (-2.89%)

15:25
03/01/17
03/01
15:25
03/01/17
15:25

Valeant reports California Department of Insurance investigations

In a regulatory filing, Valeant disclosed that on or about September 16, 2016, the company received an investigative subpoena from the California Department of Insurance. The materials requested include documents concerning the company's former relationship with Philidor and certain California-based pharmacies, the marketing and distribution of its products in California, the billing of insurers for its products being used by California residents, and other matters. Also, on May 4, 2016, Bausch & Lomb International received from the Office of the California Insurance Commissioner an administrative subpoena to produce books, records and documents. On September 1, 2016, a revised and corrected subpoena, issued to B&L Inc., was received naming that entity in place of B&L International and seeking additional books records and documents. The requested books, records and documents are being requested in connection with an investigation by the California Department of Insurance and relate to, among other things, consulting agreements and financial arrangements between B&L and healthcare professionals in California, the provision of ocular equipment, including the Victus femtosecond laser platform, by B&L to healthcare professionals in California and prescribing data for prescriptions written by healthcare professionals in California for certain of B&L's products, including the Crystalens, Lotemax, Besivance and Prolensa. The company said it is cooperating with the investigations, adding that it "cannot predict the outcome or the duration of this investigation or any other legal proceedings or any enforcement actions or other remedies that may be imposed."

  • 02

    Mar

  • 14

    Mar

VRX Valeant
$13.97

-0.415 (-2.89%)

02/28/17
WELS
02/28/17
NO CHANGE
WELS
Underperform
All Valeant franchises 'stagnating or in decline,' says Wells Fargo
In a post-earnings research note titled "Saying It Does Not Make It So," Wells Fargo analyst David Maris tells investors to review Valeant Pharmaceuticals' financial statement facts "very carefully." Valeant appears to claim victory in its earnings release by stating it has stabilized and strengthened its business, but its franchises "all appear to be stagnating or in decline and cash generation continues to deteriorate," Maris writes. He points out the company's adjusted EBITDA declined 20% in 2016 and 24% in Q4 relative to last year. Maris says his first look at the Q4 results indicate a worse than expected quarter. He keeps an Underperform rating on Valeant with a $10-$13 price target range. The stock in early trading is down 10%, or $1.75, to $14.96.
03/01/17
JPMS
03/01/17
NO CHANGE
Target $15
JPMS
Neutral
JPMorgan sees 'challenging' year for Valeant, cuts target to $15
After speaking with management following the Q4 earnings report, JPMorgan analyst Chris Schott believes 2017 will be a "challenging" year for Valeant Pharmaceuticals due to "significant" generic pressures, currency headwinds and the "negative drag" from announced divestitures. The analyst continues to see a "long road to recovery" for the Valeant story. He cut his price target for the shares to $15 from $22 after lowering again his 2017 estimates for sales, earnings and EBITDA. Schott keeps a Neutral rating on Valeant. The drugmaker closed yesterday down 14%, or $2.33, to $14.38 following its Q4 earnings report.
03/01/17
ADAM
03/01/17
NO CHANGE
Target $17
ADAM
Hold
Valeant guidance portends weaker outlook, says Canaccord
Canaccord analyst Neil Maruoka noted Valeant announced inline Q4 results and guidance that was below expectations. He believes the lowered guidance did not reflect the impact of recent divestitures, meaning guidance could be lowered further. Maruoka maintained his Hold rating and lowered his price target to $17 from $19 on Valeant shares.
03/01/17
BMOC
03/01/17
NO CHANGE
Target $19
BMOC
Market Perform
Valeant price target lowered to $19 from $21 at BMO Capital
BMO Capital analyst Gary Nachman noted that Valeant management struck a cautious tone along with its 2017 guidance and he lowered his estimates "meaningfully" in the wake of its report and outlook commentary. The analyst, who cut his price target on Valeant shares to $19 from $21, keeps a Market Perform rating on the stock, citing caution on its ability to accelerate debt paydown and the wait for improved execution.

TODAY'S FREE FLY STORIES

BABA

Alibaba

$159.50

1.75 (1.11%)

, WMT

Wal-Mart

$80.98

0.21 (0.26%)

20:25
08/16/17
08/16
20:25
08/16/17
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

BABA

Alibaba

$159.50

1.75 (1.11%)

WMT

Wal-Mart

$80.98

0.21 (0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 17

    Aug

  • 17

    Aug

  • 18

    Aug

  • 16

    Nov

  • 20

    Feb

ATU

Actuant

$22.90

-0.2 (-0.87%)

19:22
08/16/17
08/16
19:22
08/16/17
19:22
Hot Stocks
Actuant agrees to divest Viking SeaTech, acquire Mirage Machines »

Actuant Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVO

Novo Nordisk

$46.41

0.9 (1.98%)

19:17
08/16/17
08/16
19:17
08/16/17
19:17
Hot Stocks
Novo Nordisk: SUSTAIN 7 results show superior reduction in HbA1c »

Novo Nordisk announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

GOOG

Alphabet

$926.96

4.74 (0.51%)

, GOOGL

Alphabet Class A

$944.27

6.19 (0.66%)

18:48
08/16/17
08/16
18:48
08/16/17
18:48
Periodicals
Google acquires AIMatter, TechCrunch reports »

Google has acquired…

GOOG

Alphabet

$926.96

4.74 (0.51%)

GOOGL

Alphabet Class A

$944.27

6.19 (0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 18

    Aug

  • 24

    Aug

SRUN

Silver Run

$10.19

0.01 (0.10%)

18:37
08/16/17
08/16
18:37
08/16/17
18:37
Hot Stocks
Silver Run merging with Alta Mesa and Kingfisher Midstream into $3.8B company »

Silver Run Acquisition…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HEI

Heico

$85.55

-0.87 (-1.01%)

18:37
08/16/17
08/16
18:37
08/16/17
18:37
Downgrade
Heico rating change at Deutsche Bank »

Heico downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 07

    Sep

GPRK

GeoPark

$8.61

-0.13 (-1.49%)

18:36
08/16/17
08/16
18:36
08/16/17
18:36
Earnings
GeoPark reports Q2 revenue $75.2M, consensus $70.38M »

Reports Q2 consolidated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

MEDP

Medpace

$31.21

-0.16 (-0.51%)

18:14
08/16/17
08/16
18:14
08/16/17
18:14
Hot Stocks
Medpace announces stock repurchase agreement with Cinven »

Medpace Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

TOUR

Tuniu

$7.76

-0.18 (-2.27%)

18:04
08/16/17
08/16
18:04
08/16/17
18:04
Earnings
Tuniu reports Q2 EPS (11c), consensus (26c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

GLDD

Great Lakes Dredge

$3.85

-0.15 (-3.75%)

18:03
08/16/17
08/16
18:03
08/16/17
18:03
Hot Stocks
Great Lakes Dredge CEO acquires 42,610 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TISI

Team

$11.10

-0.25 (-2.20%)

18:00
08/16/17
08/16
18:00
08/16/17
18:00
Hot Stocks
Team director Lois Waters purchases 17,500 shares of company stock »

Team director Lois Waters…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTAP

NetApp

$42.41

0.44 (1.05%)

17:59
08/16/17
08/16
17:59
08/16/17
17:59
Hot Stocks
Breaking Hot Stocks news story on NetApp »

NetApp says expects…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 06

    Sep

  • 14

    Sep

NTAP

NetApp

$42.41

0.44 (1.05%)

17:58
08/16/17
08/16
17:58
08/16/17
17:58
Hot Stocks
Breaking Hot Stocks news story on NetApp »

NetApp says expects…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 06

    Sep

  • 14

    Sep

NTAP

NetApp

$42.42

0.44 (1.05%)

17:52
08/16/17
08/16
17:52
08/16/17
17:52
Earnings
NetApp sees low double digit EPS growth for FY18, consensus $3.03 »

Sees FY18 adjusted gross…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 06

    Sep

  • 14

    Sep

SFST

Southern First Bancshares

$36.00

0.05 (0.14%)

17:50
08/16/17
08/16
17:50
08/16/17
17:50
Hot Stocks
Southern First Bancshares CFO Michael Dowling sells 5,850 shares »

Southern First Bancshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

BXE

Bellatrix Exploration

$2.40

-0.03 (-1.23%)

17:49
08/16/17
08/16
17:49
08/16/17
17:49
Hot Stocks
Bellatrix Exploration regains NYSE minimum price compliance »

Bellatrix Exploration…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTAP

NetApp

$42.41

0.44 (1.05%)

17:48
08/16/17
08/16
17:48
08/16/17
17:48
Hot Stocks
NetApp says headwind for services revenue to decrease in coming quarters »

Comments from Q1 earnings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 06

    Sep

  • 14

    Sep

ACHN

Achillion

$4.88

-0.12 (-2.40%)

17:45
08/16/17
08/16
17:45
08/16/17
17:45
Conference/Events
Achillion management to meet with William Blair »

Group dinner to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

BCOR

Blucora

$23.35

0.1 (0.43%)

, BBOX

Black Box

$3.75

-0.25 (-6.25%)

17:35
08/16/17
08/16
17:35
08/16/17
17:35
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: Blucora (BCOR),…

BCOR

Blucora

$23.35

0.1 (0.43%)

BBOX

Black Box

$3.75

-0.25 (-6.25%)

BGG

Briggs & Stratton

$24.09

0.29 (1.22%)

LB

L Brands

$39.55

0.5 (1.28%)

VIPS

Vipshop

$11.10

-0.07 (-0.63%)

SPTN

SpartanNash

$25.96

0.07 (0.27%)

SNPS

Synopsys

$79.09

0.86 (1.10%)

CSCO

Cisco

$32.34

0.25 (0.78%)

NTAP

NetApp

$42.41

0.44 (1.05%)

LAKE

Lakeland Industries

$15.65

-0.25 (-1.57%)

GCP

GCP Applied Technologies

$28.75

0.1 (0.35%)

FNGN

Financial Engines

$34.35

-0.1 (-0.29%)

ACHC

Acadia

$51.68

-0.33 (-0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 16

    Aug

  • 16

    Aug

  • 17

    Aug

  • 17

    Aug

  • 17

    Aug

  • 29

    Aug

  • 06

    Sep

  • 06

    Sep

  • 06

    Sep

  • 14

    Sep

  • 30

    Nov

  • 17

    Aug

  • 17

    Aug

  • 17

    Aug

ANDX

Andeavor Logistics

$46.94

0.12 (0.26%)

, WNRL

Western Refining Logistics

$24.25

0.1 (0.41%)

17:26
08/16/17
08/16
17:26
08/16/17
17:26
Upgrade
Andeavor Logistics, Western Refining Logistics rating change at MUFG »

Andeavor Logistics…

ANDX

Andeavor Logistics

$46.94

0.12 (0.26%)

WNRL

Western Refining Logistics

$24.25

0.1 (0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GD

General Dynamics

$200.61

1.12 (0.56%)

17:22
08/16/17
08/16
17:22
08/16/17
17:22
Hot Stocks
General Dynamics awarded $115.3M government contract modification »

General Dynamics Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

BLVD

Boulevard Acquisition

$10.04

-0.01 (-0.10%)

17:17
08/16/17
08/16
17:17
08/16/17
17:17
Hot Stocks
Breaking Hot Stocks news story on Boulevard Acquisition »

Glazer Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FMBH

First Mid-Illinois Bancshares

$34.85

-0.33 (-0.94%)

17:17
08/16/17
08/16
17:17
08/16/17
17:17
Syndicate
First Mid-Illinois Bancshares files to sell $20M of common stock 'at-the-market' »

First Mid-Illinois…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

NCOM

National Commerce

$39.55

0.1 (0.25%)

17:16
08/16/17
08/16
17:16
08/16/17
17:16
Hot Stocks
National Commerce, FirstAtlantic Financial sign definitive merger agreement »

National Commerce…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

AMGN

Amgen

$171.39

1.35 (0.79%)

17:13
08/16/17
08/16
17:13
08/16/17
17:13
Hot Stocks
Amgen: NEJM publishes results from Repatha cognitive function trial »

Amgen announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

  • 18

    Aug

  • 08

    Sep

  • 14

    Sep

  • 02

    Dec

  • 03

    Feb

  • 17

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.